Lip and oral cavity carcinoma
Information
- Disease name
- Lip and oral cavity carcinoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01552434 | Active, not recruiting | Phase 1 | Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease | March 16, 2012 | March 31, 2026 |
| NCT02790853 | Active, not recruiting | Early Phase 1 | Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders | May 25, 2016 | May 31, 2026 |